Literature DB >> 26807639

Quality of Life in Women After Pelvic Exenteration for Gynecological Malignancies: A Multicentric Study.

Margherita Dessole, Marco Petrillo, Alessandro Lucidi, Angelica Naldini, Martina Rossi, Pierandrea De Iaco, Simone Marnitz, Jalid Sehouli, Giovanni Scambia, Vito Chiantera.   

Abstract

OBJECTIVES: This retrospective, multicentric study investigates quality-of-life issues and emotional distress in gynecological cancer survivors submitted to pelvic exenteration (PE).
METHODS: The Global Health Status scale of European Organization for Research and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire (QLQ-C30; the EORTC QLQ-CX24 (CX24), and EORTC QLQ-OV28 questionnaires were administered at least 12 months from surgery only in women with no evidence of further recurrence after PE. Statistical analysis was performed by the analysis of variance (for repeated measures.
RESULTS: Ninety-six subjects affected by gynecological malignancies receiving PE were enrolled in the study. Anterior PE was performed in 47 patients (49%), posterior PE was performed in 29 cases (30.2%), and total PE performed in 20 women (20.8%). In 38 cases (39.6%), a definitive colostomy was performed. Urinary diversion with continent pouch was created in 11 patients. (11.5%), whereas in the remaining cases, a noncontinent pouch was reconstructed. Patients showed a significant discomfort in attitude to disease (71.5 ± 4.7), body image (48.9 ± 6.4), financial difficulties (56.2 ± 5.8), gastrointestinal symptoms (constipation, 47.8 ± 5.1; diarrhea, 62.4 ± 6.6; appetite loss, 43.6 ± 6.7), insomnia (64.5 ± 6.6), Global Health Status (64.6 ± 3.8), physical functioning (65.8 ± 4.6), role functioning (58.8 ± 5.8), and emotional functioning (67.4 ± 4.2). A higher number of ostomies (hazard rate [HR], 7.613; P = 0.012), the creation of a noncontinent bladder (HR, 8.230; P = 0.009), and of definitive colostomy (HR, 8.516; P = 0.008) emerged as independent predictors of poorer Global Health Status scores. Older age (HR, 11.235; P = 0.003), vaginal/vulvar cancer (HR, 7.369; P = 0.013), total/posterior PE (HR, 7.393; P = 0.013), higher number of ostomies (HR, 7.613; P = 0.012), the creation of a noncontinent bladder (HR, 8.230; P = 0.009), and of definitive colostomy (HR, 8.516; P = 0.008) emerged as independent predictors of lower body image levels.
CONCLUSIONS: Long-term psycho-oncological support is strongly recommended. The reduction of ostomies seems the most effective way to improve patients' quality of life.

Entities:  

Mesh:

Year:  2018        PMID: 26807639     DOI: 10.1097/IGC.0000000000000612

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  11 in total

1.  Is a Vaginectomy Enough or is a Pelvic Exenteration Always Required for Surgical Treatment of Recurrent Cervical Cancer? A Propensity-Matched Study.

Authors:  Giuseppe Vizzielli; Lucia Tortorella; Carmine Conte; Vito Chiantera; Valerio Gallotta; Nazario Foschi; Martina Arcieri; Gabriella Ferrandina; Anna Fagotti; Filiberto Zattoni; Giovanni Scambia; Alfredo Ercoli
Journal:  Ann Surg Oncol       Date:  2020-10-15       Impact factor: 5.344

Review 2.  Weight and Eating Concerns in Women's Reproductive Health.

Authors:  Courtney McCuen-Wurst; Elizabeth Culnan; Nicole L Stewart; Kelly C Allison
Journal:  Curr Psychiatry Rep       Date:  2017-08-18       Impact factor: 5.285

3.  Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.

Authors:  Alli M Straubhar; Andrew J Chi; Qin C Zhou; Alexia Iasonos; Olga T Filippova; Mario M Leitao; Ibraheem O Awowole; Nadeem R Abu-Rustum; Vance A Broach; Elizabeth L Jewell; Jaspreet S Sandhu; Yukio Sonoda
Journal:  Gynecol Oncol       Date:  2021-09-10       Impact factor: 5.482

4.  Long-Term Survival, Prognostic Factors, and Quality of Life of Patients Undergoing Pelvic Exenteration for Cervical Cancer.

Authors:  Mihai Stanca; Dan Mihai Căpîlna; Mihai Emil Căpîlna
Journal:  Cancers (Basel)       Date:  2022-05-09       Impact factor: 6.575

Review 5.  Diagnostic Accuracy of 18F-FDG-PET/CT and MRI in Predicting the Tumor Response in Locally Advanced Cervical Carcinoma Treated by Chemoradiotherapy: A Meta-Analysis.

Authors:  Sharareh Sanei Sistani; Fateme Parooie; Morteza Salarzaei
Journal:  Contrast Media Mol Imaging       Date:  2021-03-02       Impact factor: 3.161

6.  Long-term survival after anterior pelvic exenteration and total vaginectomy for recurrent endometrial carcinoma with metastatic inguinal nodes at the time of surgery.

Authors:  Benjamin Margolis; Sun Woo Kim; Dennis S Chi
Journal:  Gynecol Oncol Rep       Date:  2016-12-29

7.  Pelvic Exenteration for Recurrent and Persistent Cervical Cancer.

Authors:  Lei Li; Shui-Qing Ma; Xian-Jie Tan; Sen Zhong; Ming Wu
Journal:  Chin Med J (Engl)       Date:  2018-07-05       Impact factor: 2.628

8.  Suicide and Accidental Death Among Women With Primary Ovarian Cancer: A Population-Based Study.

Authors:  Ying Chen; Kaixu Yu; Jiaqiang Xiong; Jinjin Zhang; Su Zhou; Jun Dai; Meng Wu; Shixuan Wang
Journal:  Front Med (Lausanne)       Date:  2022-03-16

9.  The impact of nutritional risk factors and sarcopenia on survival in patients treated with pelvic exenteration for recurrent gynaecological malignancy: a retrospective cohort study.

Authors:  Veronika Seebacher; Andrea Rockall; Marielle Nobbenhuis; S Aslam Sohaib; Thomas Knogler; Rosa M Alvarez; Desiree Kolomainen; John H Shepherd; Clare Shaw; Desmond P Barton
Journal:  Arch Gynecol Obstet       Date:  2021-11-03       Impact factor: 2.344

10.  The rectus abdominus myoperitoneal flap for vaginal reconstruction.

Authors:  Vishaal Gupta; Genevieve K Lennox; Allan Covens
Journal:  Gynecol Oncol Rep       Date:  2020-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.